White House rule would expand coverage of anti-obesity drugsÂ
The Congressional Budget Office estimated in October that a policy authorizing Medicare to cover these drugs would increase federal spending by about $35 billion between 2026-2034.
Search the Roll Call archive by keyword, date, Congress, section, or tags.
The Congressional Budget Office estimated in October that a policy authorizing Medicare to cover these drugs would increase federal spending by about $35 billion between 2026-2034.
Trump has said he wants his new agency, nicknamed DOGE, to complete its work by July 4, 2026, after examining all federal departments and agencies and recommending ways to cut costs.
The Biden administration said those negotiated prices, which take effect Jan. 1, 2026, would have saved Medicare $6 billion if they were in effect last year.
The Congressional Budget Office estimated that the bill would have increased the number of uninsured individuals by 23 million in 2026 relative to the existing health care law.
CMS announced the price list for the first 10 drugs, with the reduced sticker prices due to take effect on Jan. 1, 2026.
have resulted in $6 billion in savings for Medicare if they had been in effect in 2023, and will save $1.5 billion for Medicare recipients who pay out-of-pocket costs for their prescription drugs in 2026
It may be difficult for a new administration to stop drug negotiations before 2026, when the first round of drugs under Medicare Part D are open to negotiation.
The timeline would pave the way for a final waiver to be submitted for federal approval in 2026.
Prices would be published Sept. 1, taking effect in 2026.
The deal would provide $5.8 billion per year, through fiscal 2026, in mandatory funding for community health centers.
New prices take effect Jan. 1, 2026.
He said those now aged 59 would see an increase in the retirement age of three months per year beginning in 2026. The retirement age would reach 69 for those who turn 62 in 2033.